In association with Oximio

In association with Oximio

The next chapter of clinical trial services

Untapped opportunity: the growing potential of clinical trials in Georgia

Partner content

Untapped opportunity: the growing potential of clinical trials in Georgia

In the wake of Russia’s invasion of Ukraine, sponsors are increasingly evaluating other European countries to conduct their clinical trials.…

Accelerating transit times and lowering the cost of comparator sourcing for studies in Africa

Partner content

Accelerating transit times and lowering the cost of comparator sourcing for studies in Africa

The effect of post-Brexit status on clinical trial logistics

Partner content

The effect of post-Brexit status on clinical trial logistics

Africa’s last mile: Building viable vaccine supply chains

Partner content

Africa’s last mile: Building viable vaccine supply chains

Lifesaving logistics: overcoming barriers to expanded access programs

Partner content

Lifesaving logistics: overcoming barriers to expanded access programs

The logistics of extending the footprint of advanced therapy trials

Cell and gene therapy innovators are scaling up and out to reach more patients. Clinical Trials Arena spoke to the team at Oximio (formerly the SMO Group) to discuss market developments.

Photo of The logistics of extending the footprint of advanced therapy trials

Design for life: How to optimise costs and innovation in clinical trials using global sourcing strategies

Partner content

Design for life: How to optimise costs and innovation in clinical trials using global sourcing strategies

Partner content

Seven trends and market changes affecting clinical trials in 2021

Partner content

Oximio announces new Chief Operating Officer

Partner content

The SMO Group announces company name change to Oximio

Oximio’s breath of fresh air

Partner content

Oximio’s breath of fresh air

A new brand in clinical trial logistics

SUBSCRIBED

Thank you for subscribing to Clinical Trials Arena